Navigation Links
Brinks Hofer Gilson & Lione Expands to High-Tech Raleigh/Durham Area; Adds Accomplished Patent Attorneys to Its New Office
Date:7/9/2008

CHICAGO, July 9 /PRNewswire/ -- Brinks Hofer Gilson & Lione, one of the largest intellectual property law firms in the U.S., announces the opening of a new office in the Raleigh/Durham, North Carolina area and welcomes two local patent attorneys, Allen R. Baum and Joshua T. Elliott, who will be based in the Raleigh office. Mr. Baum and Mr. Elliott, formerly with The Hutchison Law Group, join the firm as partners. The office will officially be open for business on Tuesday, July 15, 2008.

"Brinks is a world leader in intellectual property law and already serves a solid client base in the Research Triangle Park (RTP) region," said Brinks president, Gary M. Ropski. "The addition of these two outstanding attorneys and the new office fits our current practice strategy and addresses an increasing demand from our clients. This expansion into the southeastern United States will allow us to build on our commitment to exceptional service to all clients."

The new Raleigh office will be located in the RTP area, one of the oldest and largest science parks in North America and home to more than 170 companies, including Fortune 100 multinational research organizations, university-based and start-up operations and a number of U.S. federal agencies.

"Josh and I are pleased to practice IP law with such a prominent and respected firm that is dedicated solely to intellectual property," said Mr. Baum. "Brinks offers us the capacity and resources to grow our prosecution practice, as well as expand our litigation service capabilities for clients we currently serve."

"Brinks has established a significant presence in the generic pharmaceutical segment," said Thomas J. Filarski, chair of the firm's Chemical Group and a lead generic pharmaceutical litigator. "The addition of Allen and Josh to our office in Raleigh will markedly enhance the scope of our pharmaceutical, chemical and biotech practice."

Allen R. Baum is a skilled patent attorney focusing his practice in the areas of pharmaceuticals, biochemistry and biotechnology. Prior to and during law school, Mr. Baum was a pharmaceutical chemist for DuPont Merck Pharmaceuticals and SmithKline Beecham. He is a past president of the Licensing Executives Society, an organization of more than 6,000 licensing professionals in the United States and Canada. He also served as the chair of the Chemical/Biotechnology Committee of the North Carolina Bar Association. Mr. Baum received his B.S. from Muhlenberg College, Allentown, PA, and his law degree from Widener University School of Law.

Joshua T. Elliott focuses his practice on patent law matters relating to biochemistry and biotechnology. His clients include technology companies involved in areas such as proteins, peptides, nucleic acids, antibodies, pharmaceuticals, proteomics and RNA interference. Mr. Elliott received his B.S. from the University of North Carolina at Chapel Hill, where he was elected a member of Phi Beta Kappa, and his law degree from the University of Dayton School of Law, where he was a Loren M. Berry Scholar and a member of the University of Dayton Law Review.

Founded in 1917, Brinks Hofer Gilson & Lione is based in Chicago with five other offices across the country serving the intellectual property needs of clients from around the world. The firm is one of the largest IP law firms in the country, with more than 170 attorneys, scientific advisors and patent agents specializing in intellectual property litigation and all aspects of patent, trademark, copyright, trade secret, unfair competition, intellectual asset management, and technology and licensing agreements. Brinks routinely handles assignments in fields as diverse as electrical, chemical, mechanical, biotechnology, pharmaceutical, nanotechnology, Internet and computer technology, as well as in trademarks and brand names for a wide variety of products and services. For additional information, visit http://www.usebrinks.com.

CONTACT:

Sydney Iglitzen

(312) 840-3163

siglitzen@usebrinks.com


'/>"/>
SOURCE Brinks Hofer Gilson & Lione
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Twenty-One Brinks Hofer Gilson & Lione Attorneys Named 2008 Illinois Super Lawyers
2. Fraunhofer and Boston University Hosted Prestigious SME Tour
3. Alliance for Medical Devices, Instrumentation and Diagnostics formed between Fraunhofer Center for Manufacturing Innovation and Boston University
4. Yves Lionel Assant is New Chairman of Gerresheimers Supervisory Board
5. SAFC Supply Solutions Expands Halal Offer in Flavors & Fragrances Product Line
6. PAREXEL Expands Global Clinical Logistics Capabilities
7. BioXcel Expands Its Capability in Business Analytics Support Services
8. Corgenix Expands Scientific Advisory Board
9. WuXi PharmaTech (NYSE: WX) Expands Collaboration With AstraZeneca
10. Sunesis Pharmaceuticals Expands Development Leadership Team to Focus on Late-Stage Development of Voreloxin (Formerly SNS-595)
11. Kendle Expands Global Clinical Pharmacology Capabilities with Acquisition of DecisionLine Clinical Research Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) ... precise treatments and faster cures for prostate cancer. Members of the Class of ... 15 countries. Read More About the Class of 2016 ... ... ...
(Date:6/23/2016)... ... ... In a new case report published today in STEM CELLS Translational Medicine, ... after being treated for breast cancer benefitted from an injection of stem cells derived ... debilitating, frequent side effect of cancer treatment. , Lymphedema refers to the ...
Breaking Biology Technology:
(Date:6/15/2016)... 2016 Transparency Market Research ... Market by Application Market - Global Industry Analysis Size Share ... the report, the  global gesture recognition market  was ... is estimated to grow at a CAGR of ... Increasing application of gesture recognition technology ...
(Date:6/3/2016)... June 3, 2016 ... Nepal hat ein ... hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, Registrierung und ... der Produktion und Implementierung von Identitätsmanagementlösungen. Zahlreiche ... im Januar teilgenommen, aber Decatur wurde als ...
(Date:6/1/2016)... -- Favorable Government Initiatives Coupled With Implementation ... to Boost Global Biometrics System Market Through 2021  ... " Global Biometrics Market By Type, By End ... - 2021", the global biometrics market is projected to ... growing security concerns across various end use sectors such ...
Breaking Biology News(10 mins):